Effect of intratympanic steroid therapy in sudden sensorineural hearing loss: Our clinical experience
Ahmet Hamdi̇ Kepekci.
Abstract
The goal of this study was to assess the efficacy of intratympanic steroid injection (ITS) in reducing irreversible sensorineural hearing loss in patients with sudden sensorineural hearing loss (SSHL). Between February 2018 and February 2024, a total of eighteen patients diagnosed with SSHL and treated with ITS were analyzed in this retrospective study. Hearing levels of all patients were determined before and after treatment. An audiometer from the brand "Interacoustics AD629 Diagnostic Audiometer" was used for audiological assessment. The data was divided into 2 groups, one for midrange frequencies mean (250-500–1000-2000 Hz) and the other for treble frequencies means hearing level (4000-80000Hz), these measures were compared before and after treatment. Hearing levels improved significantly after treatment. Mean midrange frequencies decreased from 44.35±27.23 dB pre-procedure to 35.46±29.49 dB postprocedure (p
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More InfoGot It!
